154 related articles for article (PubMed ID: 8806285)
1. Is there one successful antithyroid regimen for Graves' disease?
Braverman LE
Lancet; 1996 Sep; 348(9029):697-8. PubMed ID: 8806285
[No Abstract] [Full Text] [Related]
2. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
3. [Basedow disease--thyrostatic drugs combined with thyroxine?].
von Werder K
Fortschr Med; 1996 May; 114(14):6-7. PubMed ID: 8707240
[No Abstract] [Full Text] [Related]
4. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease.
Kallner G; Vitols S; Ljunggren JG
J Intern Med; 1996 Jun; 239(6):525-9. PubMed ID: 8656146
[TBL] [Abstract][Full Text] [Related]
5. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
6. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
7. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial evaluating a block-replacement regimen during radioiodine therapy.
Bonnema SJ; Grupe P; Boel-Jørgensen H; Brix TH; Hegedüs L
Eur J Clin Invest; 2011 Jul; 41(7):693-702. PubMed ID: 21175612
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.
Grebe SK; Feek CM; Ford HC; Fagerström JN; Cordwell DP; Delahunt JW; Toomath RJ
Clin Endocrinol (Oxf); 1998 May; 48(5):585-92. PubMed ID: 9666870
[TBL] [Abstract][Full Text] [Related]
11. Response to methimazole in Graves' disease. The European Multicenter Study Group.
Benker G; Vitti P; Kahaly G; Raue F; Tegler L; Hirche H; Reinwein D
Clin Endocrinol (Oxf); 1995 Sep; 43(3):257-63. PubMed ID: 7586593
[TBL] [Abstract][Full Text] [Related]
12. [Basedow's disease. Individual therapy of is great significance].
Hörmann R
MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
[No Abstract] [Full Text] [Related]
13. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
[TBL] [Abstract][Full Text] [Related]
14. Antithyroid drugs.
Goichot B; Vinzio S
N Engl J Med; 2005 May; 352(21):2246-7; author reply 2246-7. PubMed ID: 15917394
[No Abstract] [Full Text] [Related]
15. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications.
Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A
Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265
[TBL] [Abstract][Full Text] [Related]
16. High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis.
Dalan R; Leow MK; Ng DC
Ann Clin Biochem; 2008 Nov; 45(Pt 6):612-5. PubMed ID: 18941129
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of combined treatment with potassium bromide and methimazole in patients with Graves' disease.
Li D; Pei H; Li X; Liu X; Li X; Xie Y
J Endocrinol Invest; 2012 Dec; 35(11):971-4. PubMed ID: 22186223
[TBL] [Abstract][Full Text] [Related]
18. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of thyroxine in combination with methimazole in premenopausal female Graves' disease patients: case-control study.
Karner I; Stefanic M; Topuzović N
Croat Med J; 2004 Dec; 45(6):695-702. PubMed ID: 15578802
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions.
Chang LC; Chang CC; Chen PL; Wang SH; Chen YH; Tsai YH; Shih SR; Chiu WY; Fann CS; Yang WS; Chang TC
Expert Opin Drug Saf; 2018 Aug; 17(8):775-784. PubMed ID: 30067105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
